Not only are current restrictions on the communication between pharmaceutical companies and patients poorly crafted, says Scott Gottlieb, M.D., of the American Enterprise institute, but they belie a larger professional prejudice on the part of physicians to inappropriately try to control and shape the release of medical information.

Dr. Gottlieb debunks the erroneous facts and false assumptions on which he believes these misdirected impulses, on the part of the profession and legislators alike, are predicate